What's new

Orphan designation: Magrolimab Treatment of acute myeloid leukaemia, 11/11/2015 Withdrawn

Orphan designation: Magrolimab Treatment of acute myeloid leukaemia, 11/11/2015 Withdrawn

Mar 12, 2025 - 17:06
 0
Orphan designation: Magrolimab Treatment of acute myeloid leukaemia, 11/11/2015 Withdrawn
Orphan designation: Magrolimab Treatment of acute myeloid leukaemia, 11/11/2015 Withdrawn
Read More

Tags:

Previous Article

Orphan designation: autologous T cells transduced with lentiviral vector contain...

Next Article

US energy industry is putting profits over people, advocates say

Related Posts

Consolidated 3-year work plan for the Emergency Task Fo...

Feb 11, 2025  0

Meeting of the Medicine Shortages Single Point of Contact (SPOC) Working Party, Online, from 21 January 2025, 09:30 (CET) to 21 January 2025, 13:00 (CET)

Meeting of the Medicine Shortages Single Point of Conta...

Mar 12, 2025  0

EMEA-003063-PIP02-22

EMEA-003063-PIP02-22

Feb 26, 2025  0